Back to MACKENZIE FINANCIAL CORP MACKENZIE FINANCIAL CORP

TXGTXG
13 quarters

Position history for MACKENZIE FINANCIAL CORPMACKENZIE FINANCIAL CORP's holdings in 10x Genomics Inc Class A

MACKENZIE FINANCIAL CORP previously held 0 shares of TXG (10x Genomics Inc Class A), worth $0 as of 2025-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$658,000

Total Shares Change

-4,644

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q2
Latest
Exited
0
-100.0%
$00.0%$11.73
0
2025-Q1
Decreased
28,251
-82.4%
$246,6310.0%$9.16
0
2024-Q4
Increased
160,170
+407.3%
$2.3M0.0%$14.35
42
2024-Q3
New
31,573
-
$712,9180.0%$22.67
34
2024-Q2
Exited
0
-100.0%
$00.0%$19.45
0
2024-Q1
New
13,405
-
$503,0900.0%$37.53
33
2022-Q2
Exited
0
-100.0%
$00.0%$46.20
0
2022-Q1
Decreased
4,191
-73.3%
$319,0000.0%$74.74
0
2021-Q4
Decreased
15,718
-29.4%
$2.3M0.0%$150.88
0
2021-Q3
Increased
22,252
+10.3%
$3.2M0.0%$145.94
29
2021-Q2
Increased
20,178
+174.6%
$4M0.0%$201.33
43
2021-Q1
Increased
7,347
+58.2%
$1.3M0.0%$168.22
36
2020-Q4
New
4,644
-
$658,0000.0%$142.61
34

Other major holders of TXG: BAILLIE GIFFORD & CO, ARK Investment Management LLC, FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used